BIOS Capital Management
Latest statistics and disclosures from BIOS Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACTU, CGTX, IRD, LTRN, RNTX, and represent 99.28% of BIOS Capital Management's stock portfolio.
- Added to shares of these 1 stock: INAB.
- Started 1 new stock position in INAB.
- Reduced shares in these 2 stocks: In8bio, LTRN.
- Sold out of its position in In8bio.
- BIOS Capital Management was a net seller of stock by $-48k.
- BIOS Capital Management has $83M in assets under management (AUM), dropping by -7.07%.
- Central Index Key (CIK): 0001813845
Tip: Access up to 7 years of quarterly data
Positions held by BIOS Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 74.4 | $62M | 10M | 6.12 |
|
|
| Cognition Therapeutics (CGTX) | 9.8 | $8.1M | 6.0M | 1.35 |
|
|
| Ocuphire Pharma (IRD) | 9.0 | $7.4M | 3.7M | 2.01 |
|
|
| Lantern Pharma (LTRN) | 3.7 | $3.1M | 1.0M | 3.03 |
|
|
| Rein Therapeutics Com New (RNTX) | 2.4 | $2.0M | 1.7M | 1.16 |
|
|
| In8bio Com New (INAB) | 0.7 | $593k | NEW | 253k | 2.34 |
|
Past Filings by BIOS Capital Management
SEC 13F filings are viewable for BIOS Capital Management going back to 2024
- BIOS Capital Management 2025 Q4 filed Feb. 13, 2026
- BIOS Capital Management 2025 Q3 filed Nov. 12, 2025
- BIOS Capital Management 2025 Q2 filed Aug. 12, 2025
- BIOS Capital Management 2025 Q1 filed May 14, 2025
- BIOS Capital Management 2024 Q4 restated filed Feb. 18, 2025
- BIOS Capital Management 2024 Q4 filed Feb. 10, 2025